Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “THE UNITED STATES OF AMERICA, as represented by th”

2,147 pharma patents match "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,147
Index total 30,257
Page 54 / 90

Quick answer

This filtered view shows 2,147 pharmaceutical patents matching "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,147 results for “THE UNITED STATES OF AMERICA, as represented by th” · 30,257 patents in full index Clear search

  1. US 8383817

    Benztropine compounds and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted

  2. US 8377637

    MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer using miR-17-3P

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted

  3. US 8367058

    Method for bacteriophage delivery and amplification

    The United States of America, as represented by the Secretary of Agriculture · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted

  4. US 8361772

    Specific lysis of staphylococcal pathogens by bacteriophage phi11 endolysin

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted

  5. US 8361710

    MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer using miR-21

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 29, 2013 · Expires Jan 24, 2033

    granted

  6. US 8354115

    CD40 ligand adjuvant for respiratory syncytial virus

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Jan 15, 2013 · Expires Jan 10, 2033

    granted

  7. US 8349888

    Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted

  8. US 8349586

    Commensal strain of E. coli encoding an HIV GP41 protein

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted

  9. US 8344019

    Methods for the production of biliverdin

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted

  10. US 8338104

    Method of diagnosing poor survival prognosis colon cancer using miR-103-2

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  11. US 8337832

    Vaccine for protection against Shigella sonnei disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  12. US 8337831

    Live, oral vaccine for protection against Shigella dysenteriae serotype 1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  13. US 8337854

    Monoclonal antibodies against dengue and other viruses with deletion in Fc region

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  14. US 8337853

    Monoclonal antibodies that bind or neutralize dengue virus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted

  15. US 8323706

    Antiestrogenic glyceollins suppress human breast and ovarian carcinoma proliferation and tumorigenesis

    The United States of America, as represented by the Secretary of Agriculture · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted

  16. US 8323961

    HIV vaccines based on adenoviral vectors encoding Env from multiple clades of HIV

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted

  17. US 8318177

    Viral chemokine-antigen fusion proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  18. US 8318425

    Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein

    The United States of America, as Represented by the Secretary, Department of Human Services · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  19. US 8318666

    Use of leptin to treat metabolic abnormalities associated with lipoatrophy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  20. US 8318183

    Plasmodium liver stage antigens

    The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted

  21. US 8313789

    Methods of promoting the growth of beneficial bacteria in the gut

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 20, 2012 · Expires Nov 15, 2032

    granted

  22. US 8309527

    Immunomodulatory oligonucleotides

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted

  23. US 8303960

    Radiolabeled affibody molecules

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted

  24. US 8298541

    Live attenuated virus vaccines for La Crosse virus and other Bunyaviridae

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 30, 2012 · Expires Oct 25, 2032

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.